Allan Pacey, a professor of andrology at Britain’s Sheffield University, said the studies should not be seen as conclusive, since there were some technical difficulties in testing semen for viruses. He said the presence of SARS-CoV-2 in sperm did not show whether it is active and capable of causing infection.”However, we should not be surprised if the virus which causes COVID-19 is found in the semen of some men, since this has been shown with many other viruses such as Ebola and Zika,” he said.Sheena Lewis, a professor of reproductive medicine at Queen’s University Belfast, stressed that this was a “very small study” and said its findings were in keeping with other small studies showing low or no SARS-CoV-2 in tests of semen samples.”However, the long-term effects of SARS-CoV-2 on male reproduction are not yet known,” she said. Chinese researchers who tested sperm of men infected with COVID-19 found that a minority of them had the new coronavirus in their semen, opening up a small chance the disease could be transmitted sexually, scientists said on Thursday.A study by doctors at China’s Shangqiu Municipal Hospital of 38 men hospitalized with the disease found that six of them, or 16%, tested positive for SARS-CoV-2 in their semen.The researchers said that while the findings were preliminary and based on only a small number of infected men, more research is needed to see whether sexual transmission might play a role in the spreading COVID-19 pandemic. Topics : “Further studies are required with respect to the detailed information about virus shedding, survival time and concentration in semen,” the team wrote in a study published in JAMA Network Open.”If it could be proved that SARS-CoV-2 can be transmitted sexually … [that] might be a critical part of the prevention,” they said, “especially considering the fact that SARS-CoV-2 was detected in the semen of recovering patients.”Independent experts said the findings were interesting but should be viewed with caution and in the context of other small studies that have not found the new coronavirus in sperm.A previous small study of 12 COVID-19 patients in China in February and March found that all of them tested negative for SARS-CoV-2 in semen samples.
Wolf Administration: 100,000 Medical Marijuana Patient Certifications, First Phase II Grower/Processor Now Operational Medical Marijuana, Press Release, Public Health Harrisburg, PA – The Wolf Administration today announced that approved doctors have issued more than 100,000 patient certifications to allow patients with serious medical conditions access to the state’s medical marijuana program.“Realizing 100,000 patient certifications and seeing the first Phase II grower and processor operationalized is a testament to the hard work of the Department of Health, the many advocates for this program, and our General Assembly who passed this legislation nearly three years ago,” Governor Tom Wolf said. “It’s progress that is making a difference in the lives of many Pennsylvanians.”“Medical marijuana is an important tool for patients and physicians to treat one of the 21 approved serious medical conditions in the program,” Secretary of Health Dr. Rachel Levine said. “It’s important for patients to remember that their certification expires, and they have to visit an approved doctor to renew it. While many certifications are for 12 months, some may be for three, six or nine months, so it is important to talk with your doctor to set up your recertification appointment.”In addition, the department approved the first Phase II medical marijuana grower/processor, FarmaceuticalRx, LLC, located in Farrell, Mercer County, to begin operations, bringing the total number of operational grower/processors to 13. In order to become operational, each grower/processor and dispensary must complete an operational checklist and go through multiple site inspections.More than 131,000 patients in Pennsylvania have registered to participate in the medical marijuana program, and close to 102,000 have received their patient certification and are able to purchase medical marijuana at a dispensary. In addition to patients, more than 1,500 physicians have registered for the program, 1,099 of whom have been approved as practitioners. More than 780,000 dispensing events have occurred at medical marijuana dispensaries across Pennsylvania, with more than 2.2 million products sold.The medical marijuana program was signed into law by Governor Tom Wolf on April 17, 2016. Since that time, the department has:• Completed temporary regulations to enact the program;• Convened the Medical Marijuana Advisory Board;• Approved six training providers for physician continuing education;• Approved four laboratories to test this medication before it is delivered to patients;• Registered more than 131,000 patients and issued more than 100,000 patient certifications;• Validated more than 780,000 dispensing events and more than 2,200,000 products sold;• Issued 25 grower/processors permits, 13 of which are operational;• Issued 50 dispensary permits and approved 46 locations to begin operations; and• Certified eight medical schools as Academic Clinical Research Centers.The medical marijuana program offers medical marijuana to patients who are residents of Pennsylvania and under an approved practitioner’s care for the treatment of a serious medical condition as defined by the Medical Marijuana Law.For more information about the medical marijuana program, visit www.medicalmarijuana.pa.gov or follow the Department of Health on Facebook and Twitter. April 04, 2019 SHARE Email Facebook Twitter